首页> International journal of pharmaceutics> Development of a screening platform for the formulation of poorly water-soluble drugs as albumin-stabilized nanosuspensions using nab™ technology.

Development of a screening platform for the formulation of poorly water-soluble drugs as albumin-stabilized nanosuspensions using nab™ technology.

导出 LinkOut

翻译打印收藏纠错

第一作者： Annika,Adick

第一单位： Institute of Pharmaceutical Technology and Biopharmacy, University Muenster, Corrensstraße 48, 48149 Muenster, Germany. Electronic address: annika.adick@uni-muenster.de.

作者： Annika,Adick ^[1] ; Werner,Hoheisel ^[2] ; Stefan,Schneid ^[3] ; Sarah,Hester ^[4] ; Klaus,Langer ^[5]

作者单位： Institute of Pharmaceutical Technology and Biopharmacy, University Muenster, Corrensstraße 48, 48149 Muenster, Germany. Electronic address: annika.adick@uni-muenster.de. ^[1] Bayer AG, Process Technologies, Chempark, Building E41, 51368 Leverkusen, Germany. Electronic address: werner.hoheisel@bayer.com. ^[2] Bayer AG, Pharmaceuticals, Drug Product Development, Friedrich-Ebert-Straße 217-333, 42117 Wuppertal, Germany. Electronic address: stefan.schneid@bayer.com. ^[3] Institute of Pharmaceutical Technology and Biopharmacy, University Muenster, Corrensstraße 48, 48149 Muenster, Germany. Electronic address: sarah.hester@uni-muenster.de. ^[4] Institute of Pharmaceutical Technology and Biopharmacy, University Muenster, Corrensstraße 48, 48149 Muenster, Germany. Electronic address: k.langer@uni-muenster.de. ^[5]

关键词 Drug delivery system Human serum albumin Nab? technology Nanoparticles Poorly water-soluble drugs Screening